These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 38704938
1. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance. Yu L, Ren R, Li S, Zhang C, Chen C, Lv H, Zou Z, Pei X, Song Z, Zhang P, Wang H, Yang G. Eur J Med Chem; 2024 Jun 05; 272():116466. PubMed ID: 38704938 [Abstract] [Full Text] [Related]
3. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance. Ren Q, Yang G, Guo M, Guo J, Li Y, Lu J, Yang Q, Tang H, Li Y, Fang X, Sun Y, Qi JG, Tian J, Wang H. Eur J Med Chem; 2019 Jan 01; 161():118-130. PubMed ID: 30347326 [Abstract] [Full Text] [Related]
5. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S, Braconi L, Trezza A, Menicatti M, Contino M, Coronnello M, Chiaramonte N, Manetti D, Perrone MG, Romanelli MN, Udomtanakunchai C, Colabufo NA, Bartolucci G, Spiga O, Salerno M, Teodori E. Eur J Med Chem; 2019 Jun 15; 172():71-94. PubMed ID: 30947123 [Abstract] [Full Text] [Related]
6. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance. Guo M, Ren Q, Wang B, Ji W, Ni J, Feng Y, Bi Y, Tian J, Wang H. Eur J Med Chem; 2019 Nov 15; 182():111668. PubMed ID: 31505451 [Abstract] [Full Text] [Related]
7. 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers. Braconi L, Bartolucci G, Contino M, Chiaramonte N, Giampietro R, Manetti D, Perrone MG, Romanelli MN, Colabufo NA, Riganti C, Dei S, Teodori E. J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):974-992. PubMed ID: 32253945 [Abstract] [Full Text] [Related]
8. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. Munagala S, Sirasani G, Kokkonda P, Phadke M, Krynetskaia N, Lu P, Sharom FJ, Chaudhury S, Abdulhameed MD, Tawa G, Wallqvist A, Martinez R, Childers W, Abou-Gharbia M, Krynetskiy E, Andrade RB. Bioorg Med Chem; 2014 Feb 01; 22(3):1148-55. PubMed ID: 24405813 [Abstract] [Full Text] [Related]
9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo. Zhang Z, Ma C, Li P, Wu M, Ye S, Fu L, Xu J. Cell Commun Signal; 2019 Sep 01; 17(1):110. PubMed ID: 31472682 [Abstract] [Full Text] [Related]
10. Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents. Zhu J, Wang R, Lou L, Li W, Tang G, Bu X, Yin S. J Med Chem; 2016 Jul 14; 59(13):6353-69. PubMed ID: 27328029 [Abstract] [Full Text] [Related]
14. Diterpenoids from Euphorbia glomerulans with potential reversal activities against P-glycoprotein-mediated multidrug resistance. Hasan A, Tang D, Nijat D, Yang H, Aisa HA. Bioorg Chem; 2021 Dec 15; 117():105442. PubMed ID: 34742027 [Abstract] [Full Text] [Related]